1nhaler Raises £2M in Funding

Scottish medtech 1nhaler draws in £2M funding to develop single-use cardboard-based inhaler — TFN

1nhaler, a UK-based drug delivery device developer, has secured £2 million in funding led by Archangels. The funding will enable 1nhaler to work with companies around the world to bring new and existing drugs to patients. 1nhaler's innovative breath-activated, single-dose, disposable dry powder inhaler is the size of a credit card and made from recyclable cardboard. 

1nhaler Secures £2 Million to Expand Drug Delivery Innovation

1nhaler is an Edinburgh, Scotland, UK-based drug delivery device developer that has created a breath-activated, single dose, disposable dry powder inhaler that is the size of a credit card. The company's patented mechanism for drug delivery allows to transform from its basic 2D flat shape into a 3D inhaler that can deliver a broad variety of inhalable drugs. This device is made from cardboard and completely flat in storage, making it portable, distributable and recyclable.

1nhaler is a UK-based company developing a breath-activated, single-dose, disposable dry powder inhaler the size of a credit card.

2 years ago

1nhaler Secures £2 Million to Expand Drug Delivery Innovation

ProblemHealthcare

Solution

Covered on